RETHARIAN Trademark

Trademark Overview


On Friday, October 31, 2014, a trademark application was filed for RETHARIAN with the United States Patent and Trademark Office. The USPTO has given the RETHARIAN trademark a serial number of 86441540. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 3, 2017. This trademark is owned by Eli Lilly and Company. The RETHARIAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutic...
retharian

General Information


Serial Number86441540
Word MarkRETHARIAN
Filing DateFriday, October 31, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 3, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Translation of Words in MarkThe wording "RETHARIAN" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 13, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, July 3, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 3, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 17, 2016EXTENSION 3 GRANTED
Tuesday, November 22, 2016EXTENSION 3 FILED
Tuesday, November 22, 2016TEAS EXTENSION RECEIVED
Tuesday, May 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 30, 2016EXTENSION 2 GRANTED
Friday, March 25, 2016EXTENSION 2 FILED
Sunday, April 24, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 25, 2016TEAS EXTENSION RECEIVED
Friday, October 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 1, 2015EXTENSION 1 GRANTED
Friday, September 25, 2015EXTENSION 1 FILED
Thursday, October 1, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 25, 2015TEAS EXTENSION RECEIVED
Tuesday, June 2, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 7, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 7, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 2, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 2, 2015ASSIGNED TO LIE
Monday, February 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 9, 2015EXAMINER'S AMENDMENT ENTERED
Monday, February 9, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 9, 2015EXAMINERS AMENDMENT E-MAILED
Monday, February 9, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, February 9, 2015ASSIGNED TO EXAMINER
Thursday, November 13, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 4, 2014NEW APPLICATION ENTERED IN TRAM